Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. Denmark
  4. Nasdaq Copenhagen
  5. Zealand Pharma A/S
  6. News
  7. Summary
    ZEAL   DK0060257814

ZEALAND PHARMA A/S

(ZEAL)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news

European ADRs Follow Miners Lower Thursday

06/17/2021 | 11:11am EDT


ę MT Newswires 2021
All news about ZEALAND PHARMA A/S
07/30ZEALAND PHARMA A/S : Final Transactions Under Share Repurchase Program (Form 6-K..
PU
07/27ZEALAND PHARMA A/S : – Final Transactions Under Share Repurchase Program
AQ
07/21ZEALAND PHARMA A/S : Transaction Under Share Repurchase Program (Form 6-K)
PU
07/20Zealand Pharma A/S – Transaction Under Share Repurchase Program
GL
07/13ZEALAND PHARMA A/S : – Transaction Under Share Repurchase Program
AQ
07/09European ADRs Move Sharply Higher in Friday Trading
MT
07/07European ADRs Nearly Flat Wednesday as Miners, Techs Gain
MT
07/06Zealand pharma a/s - transactions under share repurchase program
GL
07/06Zealand Pharma A/S commences an Equity Buyback Plan, under the authorization ..
CI
07/06European ADRs Move Sharply Lower in Tuesday Trading
MT
More news
Financials
Sales 2021 365 M 58,3 M 58,3 M
Net income 2021 -949 M -152 M -152 M
Net cash 2021 923 M 147 M 147 M
P/E ratio 2021 -8,73x
Yield 2021 -
Capitalization 8 301 M 1 326 M 1 326 M
EV / Sales 2021 20,2x
EV / Sales 2022 16,0x
Nbr of Employees 335
Free-Float 99,4%
Chart ZEALAND PHARMA A/S
Duration : Period :
Zealand Pharma A/S Technical Analysis Chart | ZEAL | DK0060257814 | MarketScreener
Technical analysis trends ZEALAND PHARMA A/S
Short TermMid-TermLong Term
TrendsNeutralBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 8
Last Close Price 191,10 DKK
Average target price 262,86 DKK
Spread / Average Target 37,5%
EPS Revisions
Managers and Directors
Emmanuel Dulac President & Chief Executive Officer
Matthew D. Dallas Chief Financial Officer & Senior Vice President
Alf Gunnar Martin Nicklasson Chairman
Adam Sinding Steensberg Chief Medical Officer, EVP-Research & Development
Danilo Verge Head-Global Medical Affairs
Sector and Competitors
1st jan.Capi. (M$)
ZEALAND PHARMA A/S-13.37%1 326
GILEAD SCIENCES, INC.17.22%85 723
BIONTECH SE317.33%82 168
WUXI APPTEC CO., LTD.36.10%69 241
REGENERON PHARMACEUTICALS18.94%59 765
VERTEX PHARMACEUTICALS-16.09%51 450